A detailed history of Invesco Ltd. transactions in Pulmonx Corp stock. As of the latest transaction made, Invesco Ltd. holds 11,665 shares of LUNG stock, worth $73,956. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,665
Previous 25,638 54.5%
Holding current value
$73,956
Previous $326,000 66.87%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$8.71 - $14.65 $121,704 - $204,704
-13,973 Reduced 54.5%
11,665 $108,000
Q4 2023

Feb 12, 2024

SELL
$7.89 - $13.14 $35,765 - $59,563
-4,533 Reduced 15.02%
25,638 $326,000
Q3 2023

Nov 13, 2023

BUY
$9.88 - $14.0 $162,476 - $230,230
16,445 Added 119.81%
30,171 $311,000
Q2 2023

Aug 11, 2023

SELL
$10.78 - $13.65 $1.74 Million - $2.2 Million
-161,093 Reduced 92.15%
13,726 $179,000
Q1 2023

May 12, 2023

BUY
$7.49 - $12.54 $1.22 Million - $2.04 Million
162,450 Added 1313.36%
174,819 $1.95 Million
Q4 2022

Feb 13, 2023

SELL
$4.92 - $17.35 $7,158 - $25,244
-1,455 Reduced 10.53%
12,369 $104,000
Q3 2022

Nov 14, 2022

BUY
$15.35 - $23.99 $27,399 - $42,822
1,785 Added 14.83%
13,824 $230,000
Q2 2022

Aug 15, 2022

BUY
$14.0 - $27.95 $20,258 - $40,443
1,447 Added 13.66%
12,039 $178,000
Q1 2022

May 16, 2022

SELL
$21.13 - $35.65 $4,247 - $7,165
-201 Reduced 1.86%
10,592 $262,000
Q4 2021

Feb 14, 2022

SELL
$29.72 - $45.1 $30,373 - $46,092
-1,022 Reduced 8.65%
10,793 $346,000
Q3 2021

Nov 15, 2021

SELL
$35.98 - $44.48 $5.78 Million - $7.15 Million
-160,709 Reduced 93.15%
11,815 $426,000
Q2 2021

Aug 17, 2021

SELL
$37.61 - $48.0 $559,298 - $713,808
-14,871 Reduced 7.94%
172,524 $7.61 Million
Q1 2021

May 17, 2021

SELL
$44.0 - $67.54 $2.79 Million - $4.28 Million
-63,378 Reduced 25.27%
187,395 $8.57 Million
Q4 2020

Feb 16, 2021

BUY
$39.31 - $69.02 $9.86 Million - $17.3 Million
250,773 New
250,773 $17.3 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.